Purchase Order 75N95020P00524
Award Date 9/10/20
Potential Completion Date 10/31/20
Potential Value $93K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jackson, MI 49203, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA) awarded a $25,000 firm fixed-price purchase order to Biopac Systems, Inc. on July 22, 2025, with completion targeted for September 22, 2025. This contract supports NIDA's Intramural Research Program (IRP) acquisition of a physiological measurement system necessary for the bio-sensing and bio-prediction component of ecological momentary assessment (EMA) and just-in-time adaptive intervention (JITAI) studies. The award was not set aside for small...
- The National Institute on Drug Abuse (NIDA) awarded a $15.7K purchase order to Biomed Services, Inc. for the procurement and installation of two vital sign monitors to support ongoing clinical operations and ensure participant safety across active clinical protocols. The contract, which carries a firm fixed-price structure with no set-aside designation, was awarded on July 23, 2025, with an ultimate completion date of September 23, 2025. Work will be performed at NIDA's facilities in...
- The National Institute on Drug Abuse (NIDA), on behalf of the National Institute on Aging (NIA), awarded a $30,000.00 firm-fixed-price purchase order to Alamar Biosciences, Inc. to provide three 120 CNS kits to be used on the Alamar NULISA platform. These kits contain over 120 disease markers and will support research by the NIA's Laboratory of Clinical Investigation into biomarkers of neurodegenerative diseases found in exosomes isolated from patients' plasma. The award is a sole-source...
- The National Institute on Drug Abuse awarded a $1.23 million firm fixed-price purchase order to Hamilton Company for an Automated Cell Culture Processing System. The contract, awarded September 10, 2020, with a completion date of April 10, 2021, represents the de-obligation of unexpended and expiring fiscal year 2020 funding in accordance with 31 U.S.C. Section 1552(a). Hamilton Company, a Nevada-based manufacturer of precision laboratory equipment and automated liquid handling workstations,...
- The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a firm fixed-price purchase order valued at $99,500.00 to Certified Scientific Instrument, Inc. for the acquisition of used equipment. The requirement was a competitive solicitation with no set-aside designation. The contract includes three (3) Beckman Coulter BioRapTR microfluidic workstations and one (1) Perkin Elmer ViewLux ultraHTS Multilabel Reader with Stacker. The items are to be delivered within 30 days of the...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency under the U.S. Department of Health and Human Services, to the prime contractor BMG Labtechnologies Inc. The $91,438.75 firm-fixed-price purchase order was awarded on March 1, 2016, with a completion date of May 1, 2016. The contract was set aside for a small business vendor. BMG Labtechnologies Inc. is a leading global manufacturer and supplier of specialized laboratory equipment, primarily...
- <p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $11,685 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The firm fixed price contract is to provide research and development systems in support of NIH/NIDA programs addressing substance abuse and addiction. Performance will take place in Minneapolis over a two week period concluding on August 1, 2023. No subcontractors or set aside designations were...
- The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $80,650.96 firm fixed price purchase order contract to Revvity Health Sciences, Inc. for the procurement of a MicroBeta2 plate reader and a cell harvester. The contract has a period of performance through July 29, 2021. This purchase supports NIDA's research and development efforts in brain receptor imaging and investigating promising compounds. The award did not utilize any small business set-aside. Revvity Health...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $241,407.00 firm fixed price purchase order to Becton, Dickinson And Company (BD), a global medical technology company, for the acquisition of a fluorescence-activated cell sorting (FACS) Melody system. This FACS system will be primarily used by the Behavioral Neuroscience Research Branch to isolate fluorescently labeled cells and nuclei from the brain to assess molecular and...